{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:20:51Z","timestamp":1784179251980,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"ELAN program","award":["12-01-04-1"],"award-info":[{"award-number":["12-01-04-1"]}]},{"name":"ELAN program","award":["FSt56610036"],"award-info":[{"award-number":["FSt56610036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00415-018-9009-2","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T02:40:05Z","timestamp":1534732805000},"page":"2404-2414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations"],"prefix":"10.1007","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-3389","authenticated-orcid":false,"given":"Jochen A.","family":"Sembill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Y.","family":"Wieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian I.","family":"Spr\u00fcgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan T.","family":"Gerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Giede-Jeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker Y.","family":"Ey\u00fcpoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hoelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"L\u00fccking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji B.","family":"Kuramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen B.","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"issue":"8","key":"9009_CR1","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/STROKEAHA.115.009087","volume":"46","author":"J Pennlert","year":"2015","unstructured":"Pennlert J, Asplund K, Carlberg B, Wiklund PG, Wisten A, Asberg S, Eriksson M (2015) Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation. Stroke 46(8):2094\u20132099. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.115.009087","journal-title":"Stroke"},{"issue":"6","key":"9009_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","volume":"132","author":"PB Nielsen","year":"2015","unstructured":"Nielsen PB, Larsen TB, Skjoth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY (2015) Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study. Circulation 132(6):517\u2013525. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015735","journal-title":"Circulation"},{"key":"9009_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.014643","author":"J Pennlert","year":"2016","unstructured":"Pennlert J, Overholser R, Asplund K, Carlberg B, Van Rompaye B, Wiklund PG, Eriksson M (2016) Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.014643","journal-title":"Stroke"},{"issue":"6","key":"9009_CR4","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/STROKEAHA.114.005060","volume":"45","author":"J Pennlert","year":"2014","unstructured":"Pennlert J, Eriksson M, Carlberg B, Wiklund PG (2014) Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke 45(6):1839\u20131841. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.005060","journal-title":"Stroke"},{"issue":"8","key":"9009_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jama.2015.0846","volume":"313","author":"JB Kuramatsu","year":"2015","unstructured":"Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Flechsenhar J, Neugebauer H, Juttler E, Grau A, Palm F, Rother J, Michels P, Hamann GF, Huwel J, Hagemann G, Barber B, Terborg C, Trostdorf F, Bazner H, Roth A, Wohrle J, Keller M, Schwarz M, Reimann G, Volkmann J, Mullges W, Kraft P, Classen J, Hobohm C, Horn M, Milewski A, Reichmann H, Schneider H, Schimmel E, Fink GR, Dohmen C, Stetefeld H, Witte O, Gunther A, Neumann-Haefelin T, Racs AE, Nueckel M, Erbguth F, Kloska SP, Dorfler A, Kohrmann M, Schwab S, Huttner HB (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313(8):824\u2013836. \n                    https:\/\/doi.org\/10.1001\/jama.2015.0846","journal-title":"JAMA"},{"key":"9009_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.116.015150","author":"I Hernandez","year":"2016","unstructured":"Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S (2016) Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation. Stroke. \n                    https:\/\/doi.org\/10.1161\/strokeaha.116.015150","journal-title":"Stroke"},{"issue":"12","key":"9009_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/wnl.0000000000000256","volume":"82","author":"AA Rabinstein","year":"2014","unstructured":"Rabinstein AA, Gupta A (2014) Restarting anticoagulation after intracranial hemorrhage: a risky decision with no recipe. Neurology 82(12):1016\u20131017. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000000256","journal-title":"Neurology"},{"issue":"5","key":"9009_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.25079","volume":"82","author":"A Biffi","year":"2017","unstructured":"Biffi A, Kuramatsu JB, Leasure A, Kamel H, Kourkoulis C, Schwab K, Ayres AM, Elm J, Gurol ME, Greenberg SM, Viswanathan A, Anderson CD, Schwab S, Rosand J, Testai FD, Woo D, Huttner HB, Sheth KN (2017) Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann Neurol 82(5):755\u2013765. \n                    https:\/\/doi.org\/10.1002\/ana.25079","journal-title":"Ann Neurol"},{"issue":"7","key":"9009_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","volume":"9","author":"T Steiner","year":"2014","unstructured":"Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, Forsting M, Harnof S, Klijn CJ, Krieger D, Mendelow AD, Molina C, Montaner J, Overgaard K, Petersson J, Roine RO, Schmutzhard E, Schwerdtfeger K, Stapf C, Tatlisumak T, Thomas BM, Toni D, Unterberg A, Wagner M, European Stroke O (2014) European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 9(7):840\u2013855. \n                    https:\/\/doi.org\/10.1111\/ijs.12309","journal-title":"Int J Stroke"},{"issue":"7","key":"9009_CR10","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/str.0000000000000069","volume":"46","author":"JC Hemphill III","year":"2015","unstructured":"Hemphill JC IIIrd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 46(7):2032\u20132060. \n                    https:\/\/doi.org\/10.1161\/str.0000000000000069","journal-title":"Stroke"},{"issue":"9","key":"9009_CR11","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1161\/STROKEAHA.114.006202","volume":"45","author":"M Pasquini","year":"2014","unstructured":"Pasquini M, Charidimou A, van Asch CJ, Baharoglu MI, Samarasekera N, Werring DJ, Klijn CJ, Roos YB, Al-Shahi Salman R, Cordonnier C (2014) Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage. Stroke 45(9):2643\u20132648. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.006202","journal-title":"Stroke"},{"issue":"10","key":"9009_CR12","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1161\/STROKEAHA.117.017082","volume":"48","author":"LB Goldstein","year":"2017","unstructured":"Goldstein LB (2017) Anticoagulation in patients with atrial fibrillation in the setting of prior hemorrhage: an ongoing dilemma. Stroke 48(10):2654\u20132659. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.117.017082","journal-title":"Stroke"},{"issue":"6","key":"9009_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","volume":"48","author":"SB Murthy","year":"2017","unstructured":"Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, Sheth KN, Hanley DF, Ziai WC, Kamel H (2017) Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke 48(6):1594\u20131600. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.016327","journal-title":"Stroke"},{"issue":"4","key":"9009_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.029","volume":"27","author":"JA Sembill","year":"2018","unstructured":"Sembill JA, Sprugel MI, Gerner ST, Beuscher VD, Giede-Jeppe A, Stocker M, Hoelter P, Lucking H, Kuramatsu JB, Huttner HB (2018) Influence of prior nicotine and alcohol use on functional outcome in patients after intracerebral hemorrhage. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 27(4):892\u2013899. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.10.029","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"issue":"5","key":"9009_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093\u20131100. \n                    https:\/\/doi.org\/10.1378\/chest.10-0134","journal-title":"Chest"},{"issue":"2","key":"9009_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272. \n                    https:\/\/doi.org\/10.1378\/chest.09-1584","journal-title":"Chest"},{"issue":"21","key":"9009_CR17","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","volume":"113","author":"WM Lijfering","year":"2009","unstructured":"Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyak K, Prins MH, Buller HR, van der Meer J (2009) Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 113(21):5314\u20135322. \n                    https:\/\/doi.org\/10.1182\/blood-2008-10-184879","journal-title":"Blood"},{"issue":"19","key":"9009_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/eurheartj\/ehy056","volume":"39","author":"JB Kuramatsu","year":"2018","unstructured":"Kuramatsu JB, Sembill JA, Gerner ST, Sprugel MI, Hagen M, Roeder SS, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker J, Rizos T, Volkmann J, Mullges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Wopking S, Ludolph AC, Stosser S, Neugebauer H, Rother J, Michels P, Schwarz M, Reimann G, Bazner H, Schwert H, Classen J, Michalski D, Grau A, Palm F, Urbanek C, Wohrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Gunther A, Hamann GF, Lucking H, Dorfler A, Achenbach S, Schwab S, Huttner HB (2018) Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J 39(19):1709\u20131723. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehy056","journal-title":"Eur Heart J"},{"issue":"4","key":"9009_CR19","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/cc12827","volume":"17","author":"JB Kuramatsu","year":"2013","unstructured":"Kuramatsu JB, Gerner ST, Lucking H, Kloska SP, Schellinger PD, Kohrmann M, Huttner HB (2013) Anemia is an independent prognostic factor in intracerebral hemorrhage: an observational cohort study. Crit Care 17(4):R148. \n                    https:\/\/doi.org\/10.1186\/cc12827","journal-title":"Crit Care"},{"issue":"11","key":"9009_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3949\/ccjm.77a.10018","volume":"77","author":"JN Goldstein","year":"2010","unstructured":"Goldstein JN, Greenberg SM (2010) Should anticoagulation be resumed after intracerebral hemorrhage? Clevel Clin J Med 77(11):791\u2013799. \n                    https:\/\/doi.org\/10.3949\/ccjm.77a.10018","journal-title":"Clevel Clin J Med"},{"issue":"3\u20134","key":"9009_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000371574","volume":"73","author":"C Gumbinger","year":"2015","unstructured":"Gumbinger C, Holstein T, Stock C, Rizos T, Horstmann S, Veltkamp R (2015) Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation. Eur Neurol 73(3\u20134):184\u2013191. \n                    https:\/\/doi.org\/10.1159\/000371574","journal-title":"Eur Neurol"},{"issue":"4","key":"9009_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/02813432.2014.984952","volume":"32","author":"C Johansson","year":"2014","unstructured":"Johansson C, Hagg L, Johansson L, Jansson JH (2014) Characterization of patients with atrial fibrillation not treated with oral anticoagulants. Scand J Prim Health Care 32(4):226\u2013231. \n                    https:\/\/doi.org\/10.3109\/02813432.2014.984952","journal-title":"Scand J Prim Health Care"},{"issue":"5","key":"9009_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0000000000004174","volume":"89","author":"JA Sembill","year":"2017","unstructured":"Sembill JA, Gerner ST, Volbers B, Bobinger T, Lucking H, Kloska SP, Schwab S, Huttner HB, Kuramatsu JB (2017) Severity assessment in maximally treated ICH patients: the max-ICH score. Neurology 89(5):423\u2013431. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004174","journal-title":"Neurology"},{"issue":"12","key":"9009_CR24","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/jamaneurol.2013.4021","volume":"70","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ (2013) New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol 70(12):1486\u20131490. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.4021","journal-title":"JAMA Neurol"},{"issue":"4","key":"9009_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ene.12215","volume":"21","author":"S Horstmann","year":"2014","unstructured":"Horstmann S, Rizos T, Jenetzky E, Gumbinger C, Hacke W, Veltkamp R (2014) Prevalence of atrial fibrillation in intracerebral hemorrhage. Eur J Neurol 21(4):570\u2013576. \n                    https:\/\/doi.org\/10.1111\/ene.12215","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9009-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9009-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9009-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:10:23Z","timestamp":1566241823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9009-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["9009"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9009-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the ethics committee of the Friedrich-Alexander-University Erlangen-Nuremberg and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from all patients or legal representatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}